2022-05-20
Kristina Torfgård, our CEO, presented Alzinova at Aktieportföljen Live on May 11.
Read more
2022-05-11
We are proud to sponsor the Alzheimer race, which takes place this weekend, May 13-15. Read more
2022-05-04
"Alzinova lägger grunden för nästa utvecklingssteg"… Read more
On May 3, Kristina Torfgård, CEO, and Anders Sandberg, CSO participated in a panel discussion on Alzheimer's disease. Read more
2022-04-14
In the article (in Swedish) linked below, our CEO, Kristina Torfgård, comments on the recent decision by the the… Read more
2022-04-10
Anders Sandberg, Chief Scientific Officer, about our improved manufacturing process for our oligomer-specific vaccine, ALZ-101. Read more
2022-03-16
We are proud to be part of the BioVentureHub on the AstraZeneca Gothenburg site in the wider GoCo Health… Read more
2022-02-04
Kristina Torfgård, CEO, Anders Sandberg, CSO, and Håkan Skogström, CFO, were interviewed by our Communications Specialist, Jamie Smith, at… Read more
2022-01-28
Check out this article (in Swedish) by BioStock - Connecting Innovation and Capital featuring an interview with our Chief… Read more
2022-01-27
On January 26, our CEO, Kristina Torfgård, presented Alzinova at Mangold Insight Life Science Investent day. Read more
2022-01-17
We're proud to be partnering with Alzheimerfonden. In line with our vision to enable patients to live an independent… Read more
2022-01-14
Our CEO, Kristina Torfgård presented Alzionva at RedEye Investor Forum Online on January 13. Read more
2022-01-12
Like us, you probably know someone who has, or has had, Alzheimer’s disease. It is a progressively debilitating disease… Read more
2022-01-05
The European Medicines Agency (EMA) recently recommended the refusal of the marketing authorisation for Aduhelm, a medicine intended for the treatment… Read more
2022-01-03
2021-12-20
“Alzinova vill knäcka Alzheimer-gåtan”… Read more
2021-11-29
On November 24, our CEO Kristina Torfgård, presented Alzinova at Aktieportföljen. Read more
2021-11-19
"Yesterday, Biogen received a negative trend vote on the aducanumab (Aduhelm) Marketing Authorization application, following an oral explanation held… Read more
2021-11-15
"Trial Testing ALZ-101 Alzheimer’s Vaccine Recruits First Patient - The first patient has been recruited, in Finland, for Alzinova… Read more
2021-11-03
Redeye AB has revisited the Alzinova equity story with the initiation of clinical trials with ALZ-101, our vaccine candidate… Read more
2021-10-29
Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments of Alzheimer’s disease by specifically targeting neurotoxic… Read more
2021-10-25
Our Chief Scientific Officer Anders Sandberg represents Alzinova at Bio-Europe Digital 2021. Read more
2021-10-18
Alzinova's CEO Kristina Torfgård was interviewed on October 13, 2021 by Redeye’s Life Science analyst Kevin Sule. Read more
2021-10-14
Our CEO, Kristina Torfgård, presented the company at the Redeye Neurology Seminar together with representatives from the other Swedish… Read more
2021-10-11
Kristina Torfgård, CEO presented Alzinova at Aktiespararnas Aktiedag, October 11 2021. Read more
2021-09-30
We are so proud and happy to have received approval to start the first clinical study with the oligomer-specific… Read more
2021-09-29
CEO Kristina Torfgård will present Alzinova and answer your questions on October 11th at 16:00 CEST, when Alzinova attends… Read more
2021-09-20
World Alzheimer's Day takes place on 21 September and is part of World Alzheimer's Month, raising awareness for this… Read more
2021-09-17
Alzinova will participate at Redeye Investor Forum Online on September 23, 2021 at 15:20 CEST, where CEO Kristina Torfgård… Read more
2021-09-01
World Alzheimer's Month is the international campaign every September to raise awareness for Alzheimer’s disease and how it impacts the daily… Read more
2021-08-27
Captario Analyst, Stephanie Mardini wrote an article on alzheimersdisease and our work to develop a potential vaccine. Check it… Read more
2021-07-07
Alzinova is participating at the AAIC 2021 (Alzheimer’s Association International Conference). Read more
2021-06-30
”We felt it was important to participate in GU Ventures' roundtable discussion at the DI Impact Summit since good health… Read more
2021-06-09
The FDA granted an accelerated approval for aducanumab on June 7, 2021. The decision to approve a new treatment… Read more
2021-06-08
The US Food and Drug Administration (FDA) communicated yesterday its decision to approve the investigational drug, aducanumab, for the… Read more
2021-06-07
In the US, June is Alzheimer's & Brain Awareness month. "The more people know about Alzheimer's, the more action… Read more
2021-06-02
2021-05-17
At Aktiespararna's Aktiedagen on Monday, our CEO, Kristina Torfgård provided an update on Alzinova and progress on the first… Read more
2021-05-05
On May 5 our CEO, Kristina Torfgård, attended the Captario Webinar together with AstraZeneca: From Small to Large in… Read more
2021-04-29
2021-04-16
Researchers are confident that it will soon be possible to do blood tests to see if there are signs… Read more
2021-04-09
Listen to the latest episode of Data, Pharma & Fika with our collaboration partner Captario, where Ingela Nylander our… Read more
2021-03-19
Our CEO, Kristina Torfgård, recently participated in a webcast discussion on Alzheimer's disease together with the CEOs of two… Read more
2021-03-03
Alzinova has recently initiated a collaboration with Captario to further optimize the company's development strategies. Read more
2021-03-01
Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund. Read more
2021-02-25
"2020 was an important year and, our goal-oriented work has ensured that we are well prepared for the start… Read more
2021-02-10
Alzinova is collaborating with prominent researchers at Sahlgrenska University Hospital in Gothenburg, Sweden, to track markers of neurodegenerative change… Read more
2021-01-18
In a Research Note posted last week, equity research and investment banking company, Redeye, commented on “another external validation”… Read more
2020-09-14
World Alzheimer's Day takes place on 21 September and is part of World Alzheimer's Month, raising awareness for this disease… Read more
2020-06-16
Alzinova, a Swedish biopharmaceutical company developing disease-modifying treatments against Alzheimer’s Disease, has moved into AstraZeneca’s BioVentureHub in Gothenburg. Read more
